Cancer Family
Pancreaticobiliary Neoplasm
CI-CAN-00000309Explore in graph →
Non-malignant1,204 active trials11 approved drugs92 evidence items
- NCIt
- C223357
Loading cancer entity…
Cancer Family
CI-CAN-00000309Explore in graph →
Clinical trials
5,004 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00010062 | Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Feb 9, 2009 | clinicaltrials |
| NCT00010088 | Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Feb 9, 2009 |
| clinicaltrials |
| NCT00275119 | Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00758381 | Metastatic Advanced Pancreas Sorafenib(MAPS) | unknown | Phase 2 | 114 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Oct 10, 2008 | clinicaltrials |
| NCT00024362 | BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery | unknown | Phase 2 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00149578 | A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 45 | National Health Research Institutes, TaiwanOTHER | 1 | May 17, 2007 | clinicaltrials |
| NCT00323583 | Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer | unknown | Phase 2 | 80 | Seattle Cancer Treatment and Wellness CenterOTHER | 1 | May 8, 2007 | clinicaltrials |
| NCT00108875 | Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer | unknown | Phase 1 / Phase 2 | 70 | Julius-Maximilians UniversityOTHER | 1 | Jul 28, 2006 | clinicaltrials |
| NCT00356161 | HAI Via Interventionally Implanted Port Catheter Systems | unknown | Phase 2 | 100 | Charite University, Berlin, GermanyOTHER | 1 | Jul 25, 2006 | clinicaltrials |
| NCT00346281 | 32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer | unknown | Phase 2 | 15 | pSiMedica LimitedINDUSTRY | 2 | Jun 29, 2006 | clinicaltrials |
| NCT00290316 | Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver | unknown | Phase 2 | — | Central Texas Veterans Health Care SystemOTHER | 1 | Jun 7, 2006 | clinicaltrials |
| NCT00197431 | Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer | unknown | Phase 2 | — | Hamamatsu UniversityOTHER | 1 | Mar 22, 2006 | clinicaltrials |
| NCT00057395 | A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 40 | Aronex PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00081549 | Aroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard Therapies | unknown | Phase 1 / Phase 2 | 111 | Aronex PharmaceuticalsINDUSTRY | 0 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Feb 9, 2009source: clinicaltrials